Home > Products > CD3 & IL2R
> Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (IgG-scFv)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (IgG-scFv) (CAT#: IGFV-093)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Hodgkin lymphoma; Non-Hodgkin's lymphoma (NHL); Acute lymphocytic leukemia (ALL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (IgG-scFv) (IGFV-093). Click the button below to contact us or submit your feedback about this product.